In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

A recent study by the ICMR National Centre for Disease Informatics and Research warns of a 5.6% annual increase in Indian breast cancer cases, driven by various risk factors.

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Luveltamab tazevibulin, a novel ADC, showed encouraging responses in platinum-resistant ovarian cancer, with a 32% ORR and a ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather ...

Zosia Miedzybrodzka has been appointed an Officer of the Order of the British Empire (OBE) for her services to genetics ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...

Angelina Jolie's long-rumored relocation plans are very much alive and gaining momentum, according to close sources.

Angelina Jolie has shockingly faced a torrent of callous online abuse after boldly baring the scars from her double ...

Angelina Jolie is reportedly preparing to leave Los Angeles behind as she plans a new life abroad focused on privacy, freedom ...

Have you ever thought of having a baby that’s gonna be the exact version from your thoughts? The ocean blue eyes, the cute ...